Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SRT3109

SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases.

Product Specifications

CAS Number

[1204707-71-0]

Product Name Alternative

AZD-5122

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

CXCR

Type

Reference compound

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/srt3109.html

Concentration

10mM

Purity

99.68

Solubility

DMSO : ≥ 100 mg/mL

Smiles

FC1=C(F)C=CC=C1CSC2=NC(NS(=O)(N3CCC3)=O)=CC(N[C@@H]([C@@H](O)CO)C)=N2

Molecular Formula

C18H23F2N5O4S2

Molecular Weight

475.53

Precautions

H302, H315, H319, H335

References & Citations

[1]Premji Meghani, et al. Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases. WO2010007427A1

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 1

Isoform

CXCR2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MHP 133
HY-101653 1 Each

MHP 133

Ask
View Details
Selplg Rat Pre-designed siRNA Set A
HY-RS24679 1 Set

Selplg Rat Pre-designed siRNA Set A

Ask
View Details
ATP5A1
307251-01 50 µg

ATP5A1

Ask
View Details
ATP5A1
307251-02 100 µg

ATP5A1

Ask
View Details
Anti-AREG antibody
STJ22665 100 µl

Anti-AREG antibody

Ask
View Details
Cdk8 (Cyclin-dependent Kinase 8, Cdk 8, Cell Division Protein Kinase 8, K35, Mediator Complex Subunit CDK8, MGC126074, MGC126075, Protein Kinase K35) (PE)
C2578-05-PE 100 µL

Cdk8 (Cyclin-dependent Kinase 8, Cdk 8, Cell Division Protein Kinase 8, K35, Mediator Complex Subunit CDK8, MGC126074, MGC126075, Protein Kinase K35) (PE)

Ask
View Details